🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/08/1981 | 0,0172 USD |
| 01/06/1981 | 0,0172 USD |
| 02/03/1981 | 0,0172 USD |
| 02/12/1980 | 0,0172 USD |
| 29/08/1980 | 0,0152 USD |
| 02/06/1980 | 0,0152 USD |
| 28/02/1980 | 0,0152 USD |
| 03/12/1979 | 0,0152 USD |
| 31/08/1979 | 0,0126 USD |
| 25/05/1979 | 0,0126 USD |
| 01/03/1979 | 0,0126 USD |
| 04/12/1978 | 0,0126 USD |
| 28/08/1978 | 0,0113 USD |
| 26/05/1978 | 0,0113 USD |
| 02/03/1978 | 0,0113 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 21/04/2021 | 75,31 | 75,85 | 75,07 | 75,60 | +0,84% | 1,04% | 11.817.248 |
| 20/04/2021 | 74,12 | 75,52 | 74,12 | 74,97 | +1,17% | 1,88% | 11.009.345 |
| 19/04/2021 | 74,14 | 74,23 | 73,44 | 74,10 | +0,25% | 1,06% | 8.536.903 |
| 16/04/2021 | 73,71 | 74,19 | 73,30 | 73,92 | +1,06% | 1,20% | 12.512.806 |
| 15/04/2021 | 72,57 | 73,79 | 72,57 | 73,15 | +0,34% | 1,68% | 14.541.734 |
| 14/04/2021 | 72,81 | 73,27 | 72,54 | 72,90 | -0,04% | 1,01% | 8.415.545 |
| 13/04/2021 | 72,49 | 73,24 | 72,40 | 72,93 | +0,28% | 1,17% | 8.627.346 |
| 12/04/2021 | 72,87 | 73,09 | 72,50 | 72,73 | -0,12% | 0,81% | 9.970.672 |
| 09/04/2021 | 72,05 | 72,88 | 71,98 | 72,81 | +1,09% | 1,26% | 8.177.439 |
| 08/04/2021 | 72,60 | 72,90 | 71,83 | 72,03 | -0,83% | 1,47% | 12.007.984 |
| 07/04/2021 | 72,60 | 72,90 | 72,25 | 72,63 | +0,44% | 0,89% | 8.970.566 |
| 06/04/2021 | 73,39 | 73,42 | 72,18 | 72,32 | -1,57% | 1,69% | 13.394.698 |
| 05/04/2021 | 73,97 | 74,34 | 73,26 | 73,47 | -0,12% | 1,46% | 9.828.144 |
| 01/04/2021 | 73,63 | 73,91 | 73,30 | 73,56 | +0,00% | 0,83% | 9.121.373 |
| 31/03/2021 | 73,57 | 74,13 | 73,13 | 73,56 | +0,17% | 1,36% | 13.598.219 |
| 30/03/2021 | 74,43 | 74,50 | 73,27 | 73,44 | -1,71% | 1,65% | 10.123.366 |
| 29/03/2021 | 73,78 | 74,95 | 73,64 | 74,71 | +1,18% | 1,78% | 11.448.562 |
| 26/03/2021 | 72,66 | 73,92 | 72,38 | 73,85 | +1,74% | 2,13% | 10.389.767 |
| 25/03/2021 | 72,92 | 73,10 | 71,86 | 72,59 | -0,22% | 1,70% | 10.700.918 |
| 24/03/2021 | 72,59 | 73,17 | 72,43 | 72,75 | -0,04% | 1,01% | 9.135.416 |
| 23/03/2021 | 73,56 | 73,78 | 72,55 | 72,78 | -1,60% | 1,67% | 11.651.245 |
| 22/03/2021 | 72,33 | 74,43 | 72,08 | 73,96 | +0,00% | 3,25% | 11.352.879 |
| 19/03/2021 | 73,71 | 74,67 | 72,54 | 73,96 | +0,31% | 2,89% | 58.225.203 |
| 18/03/2021 | 73,72 | 74,61 | 73,67 | 73,73 | -0,04% | 1,27% | 14.274.179 |
| 17/03/2021 | 73,22 | 73,95 | 72,49 | 73,76 | +0,64% | 1,99% | 17.533.878 |
| 16/03/2021 | 72,66 | 73,64 | 72,65 | 73,29 | +0,76% | 1,35% | 15.697.887 |
| 15/03/2021 | 72,04 | 73,05 | 71,64 | 72,74 | +2,18% | 1,96% | 17.999.295 |
| 12/03/2021 | 70,64 | 71,46 | 70,60 | 71,18 | -0,04% | 1,22% | 11.493.940 |
| 11/03/2021 | 71,46 | 71,91 | 71,17 | 71,21 | -0,17% | 1,03% | 13.205.324 |
| 10/03/2021 | 71,34 | 71,78 | 70,71 | 71,34 | +0,84% | 1,51% | 12.827.310 |